Showing results (2421-2430 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|June 19, 2012
Lymphocele and ovarian cancer: risk factors and impact on survivalTristan Gauthier, Catherine Uzan, Delphine Lefeuvre, et al.
The Oncologist|March 25, 2010
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancerCyril Touboul, Catherine Uzan, Audrey Mauguen, et al.
The Oncologist|May 15, 2023
Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic StudyAlberto Carmona-Bayonas, Adán Rodriguez-Gonzalez, Teresa García-García, et al.
The Oncologist|May 17, 2023
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I ResultsDamien Pouessel, Soléakhéna Ken, Valérie Gouaze-Andersson, et al.
The Oncologist|May 17, 2023
The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular InvasionJianwei Liu, Guokun Zhuang, Shilei Bai, et al.
The Oncologist|January 8, 2014
Sexual health as a survivorship issue for female cancer survivorsDon S Dizon, Daphne Suzin, Susanne McIlvenna
The Oncologist|September 26, 2012
Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancerKenny A Rodriguez-Wallberg, Kutluk Oktay
The Oncologist|September 25, 2012
U.S. Food and Drug Administration Approval: peginterferon-alfa-2b for the adjuvant treatment of patients with melanomaThomas M Herndon, Suzanne G Demko, Xiaoping Jiang, et al.
The Oncologist|October 2, 2012
Diagnosis, treatment, and follow-up of borderline ovarian tumorsDaniela Fischerova, Michal Zikan, Pavel Dundr, et al.
The Oncologist|March 4, 2015
Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one centerEva Branden, Gunnar Hillerdal, Karl Kolbeck, et al.
Pageof 571